Drug significantly reduces chorea symptoms in : comparemela.

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.

Related Keywords

United States , American , Neurocrine Biosciences , Furr Stimming , Erin Furr Stimming , Clinical Research Inc , Huntington Disease Society Of America Center , Drug Administration , University Of Rochester Medical Center , Huntington Disease Health Index , Mcgovern Medical School , Clinical Trials Coordination Center , American Academy Of Neurology , Huntington Study Group , Lancet Neurology , Memorial Hermann Chair , American Academy , Disease Society , America Center , Disease Health Index , New Drug Application , Rochester Medical Center ,